Patents by Inventor Fariello Ruggero

Fariello Ruggero has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20130053368
    Abstract: New uses of safinamide, safinamide derivatives and MAO-B inhibitors in novel types of treatment for Parkinson's Disease are described. More specifically, the invention relates to methods for treating Parkinson's Disease through the administration of safinamide, a safinamide derivative, or a MAO-B inhibitor, in combination with other Parkinson's Disease agents or treatments, such as levodopa/PDI or dopamine agonists.
    Type: Application
    Filed: August 24, 2012
    Publication date: February 28, 2013
    Applicant: Newron Pharmaceuticals S.P.A
    Inventors: Fariello Ruggero, Carlo CATTANEO, Patricia SALVATI, Luca BENATTI
  • Publication number: 20100016440
    Abstract: Methods of using certain a-aminoamide derivatives as anti-inflammatory agents. The anti-inflammatory agents of the invention are able to reduce or even stop inflammatory s conditions substantially without side effects.
    Type: Application
    Filed: August 20, 2009
    Publication date: January 21, 2010
    Applicant: NEWRON PHARMACEUTICALS S.P.A.
    Inventors: Patricia Salvati, Orietta Veneroni, Elena Barbanti, Fariello Ruggero, Luca Benatti
  • Publication number: 20070276046
    Abstract: Methods of using certain a-aminoamide derivatives as anti-inflammatory agents. The anti-inflammatory agents of the invention are able to reduce or even stop inflammatory s conditions substantially without side effects.
    Type: Application
    Filed: April 22, 2004
    Publication date: November 29, 2007
    Inventors: Patricia Salvati, Orietta Veneroni, Elena Barbanti, Fariello Ruggero, Luca Benatti
  • Publication number: 20070093495
    Abstract: New uses of safinamide, safinamide derivatives and MAO-B inhibitors in novel types of treatment for Parkinson's Disease are described. More specifically, the invention relates to methods for treating Parkinson's Disease through the administration of safinamide, a safinamide derivative, or a MAO-B inhibitor, in combination with other Parkinson's Disease agents or treatments, such as levodopa/PDI or dopamine agonists.
    Type: Application
    Filed: April 8, 2004
    Publication date: April 26, 2007
    Inventors: Fariello Ruggero, Carlo Cattaneo, Patricia Salvati, Luca Benatti